Publications & Presentations

05.16.22 || A synthetic biology approach to address the immunosuppressive tumor microenvironment: novel TGF-β switch receptors convert inhibitory signals into enhanced NK cell activity

05.16.22 || Engineered Allogeneic Car-Natural Killer Cells Resist Tumor Microenvironment Immuno-Suppression By Expression Of A Tgfbr2 Dominant Negative Receptor

04.08.22 || Allogeneic natural killer cells engineered to express HER2 CAR, interleukin 15, and TGF-beta dominant negative receptor effectively control HER2+ tumors

12.11.21 || Engineering CD70-Directed CAR-NK Cells for the Treatment of Hematological and Solid Malignancies

10.06.21 || Cryopreservation of Natural Killer and anti-CD19 Chimeric Antigen Receptor Natural Killer Cells